Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|January 2, 2024
Factors associated with the acceptability of Lopinavir/Ritonavir formulations among children living with HIV/AIDS attending care and treatment clinics in Mbeya and Mwanza, TanzaniaNadiya Alnoor Jiwa, Eunice Ketang'enyi, Kapongola Nganyanyuka, et al.
BMJ Open|March 4, 2025
Patients' acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in TanzaniaJulieth Lalashowi, Happiness Mvungi, Zawadi Mwaisango, et al.
PLOS Global Public Health|December 17, 2024
Optimizing delivery strategies for 3HP TB preventive treatment in Tanzania: A qualitative study on acceptability of family approach in HIV care and treatment centersDoreen Pamba, Erica Sanga, Killian Mlalama, et al.
The Journal of Infection|January 5, 2025
N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosisDaniel Adon Mapamba, Issa Sabi, Julieth Lalashowi, et al.
NEJM Evidence|August 27, 2024
Adjunctive N-Acetylcysteine and Lung Function in Pulmonary TuberculosisRobert S Wallis, Issa Sabi, Julieth Lalashowi, et al.
Pathogens (Basel, Switzerland)|March 29, 2023
Increased HIV Incidence in <i>Wuchereria bancrofti</i> Microfilaria Positive Individuals in TanzaniaJonathan Mnkai, Manuel Ritter, Lucas Maganga, et al.
Vaccine|August 2, 2025
Facilitators and barriers to implementation of HPV vaccination in Tanzania: a mixed-methods study exploring perspectives from national, subnational, and community stakeholders, 2018-2023Julie Garon Carlton, Doreen Pamba, Nessa Ryan, et al.
Journal of Medical Internet Research|August 18, 2025
The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods StudyCarlo Federici, Maria Verykiou, Marianna Cavazza, et al.
BMJ Global Health|August 25, 2021
Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country settingNyanda Elias Ntinginya, Davis Kuchaka, Fred Orina, et al.
JMIR Research Protocols|May 11, 2026
Safety, Tolerability, and Immunogenicity of the TANCoV-1.3.20 SARS-CoV-2 Vaccine Among Healthy Participants in Tanzania: Protocol for a Multisite, Phase 1/2a, Double-Blinded Randomized Controlled TrialGeorge Peter Judicate, Marco Missanga, Mbazi Senkoro, et al.
Pageof 3